Zevra Therapeutics, Inc. ZVRA Business Segments — Interest Expense, Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s business segments — interest expense, nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s business segments — interest expense, nonoperating?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — interest expense, nonoperating of $1.71M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s business segments — interest expense, nonoperating changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — interest expense, nonoperating decreased by 13.1% year-over-year, from $1.97M to $1.71M.
- What does business segments — interest expense, nonoperating mean?
- Captures the interest costs incurred on debt obligations that are not directly tied to core operating activities. It serves as a measure of the segment's financial leverage and the cost of servicing its capital structure.